Singlera Genomics Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Singlera Genomics Inc. - overview
Established
2014
Location
Yangzhou, Jiangsu, China
Primary Industry
Biotechnology
About
Founded in 2014 and based in Shanghai, China, Singlera Genomics Inc. is a biotechnology company that provides gene sequencing technology services. It has research centers in Shanghai and San Diego, and production bases in Yangzhou and Taizhou. The co-founder, Chairman of the board, and CEO, Jiangli Zhang, graduated from Fudan University and served as Vice President and General Manager at ThermoFisher China.
In April 2023, the company signed a strategic cooperation agreement with the Huangshan Health Commission. In June 2024, Singlera raised strategic investment for more than CNY 100 million. The company specializes in providing genetic testing solutions for cancer and genetic diseases based on molecular diagnostic technology. The services include risk assessment, early screening and diagnosis, medication guidance, and postoperative monitoring of high-incidence cancers.
The product lines cover colorectal cancer, liver cancer, stomach cancer, and other fields. The company generates revenue by providing detection solutions and products for tumors and genetic diseases. The company will use the strategic investment for technological research and development, registered production, and commercial implementation.
Current Investors
Lilly Asia Ventures, Green Pine Capital Partners, CD Capital
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Diagnostic, Medical & Imaging Laboratories, Oncology/Cancer Treatment, Diagnostic Equipment
Website
www.singlera.com.cn
Verticals
HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Singlera Genomics Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.